CDC Recommends Second Dose of 2024-2025 COVID-19 Vaccine for People 65 Years and Older and for People Who are Moderately or Severely Immunocompromised
Today, CDC Director Mandy Cohen endorsed the CDC Advisory Committee on Immunization Practices' (ACIP) recommendation for people 65 years and older and those who are moderately or severely immunocompromised to receive a second dose of 2024-2025 COVID-19 vaccine six months after their first dose.
Today, CDC Director Mandy Cohen endorsed the CDC Advisory Committee on Immunization Practices' (ACIP) recommendation for people 65 years and older and those who are moderately or severely immunocompromised to receive a second dose of 2024-2025 COVID-19 vaccine six months after their first dose.
This Coalition transmission preserves metadata, trust context, and source routing for a Public Intelligence item from CDC. The complete article remains with the original publisher.
Content handling is marked as Public Domain. Use the source article link for the full report, updates, corrections, and publisher-controlled context.
Key Points
- Published by CDC.
- Categorized as Public Intelligence.
- Source handling: Verified Source.
- Rights posture: Public Domain.
- Follow the source article for the complete original report.